Crossmark

Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya

Published Online: 2020-03-14

Published Print: 2020-12

Authors

Wekesa, Paul https://orcid.org/0000-0001-9274-7731
McLigeyo, Angela

Owuor, Kevin

Mwangi, Jonathan

Nganga, Evelyne

Masamaro, Kenneth
Funding

Funding for this research was provided by:

U.S. President’s Emergency Plan for AIDS Relief (NU2GGH002024-01-00)
License Information

Text and Data Mining valid from 2020-03-14

Version of Record valid from 2020-03-14
More Information

Article History

Received: 22 November 2019

Accepted: 28 February 2020

First Online: 14 March 2020

Ethics approval and consent to participate

: The Kenyatta National Hospital - University of Nairobi Ethics Review Committee. This study was reviewed according to the Centers for Disease Control and Prevention (CDC) human research protection procedures and was determined to be and approved as research, but CDC was not engaged. As this research was retrospective, consent from study participants was not required.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current